JP2024520421A5 - - Google Patents
Info
- Publication number
- JP2024520421A5 JP2024520421A5 JP2023572788A JP2023572788A JP2024520421A5 JP 2024520421 A5 JP2024520421 A5 JP 2024520421A5 JP 2023572788 A JP2023572788 A JP 2023572788A JP 2023572788 A JP2023572788 A JP 2023572788A JP 2024520421 A5 JP2024520421 A5 JP 2024520421A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- fusion protein
- deletions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025086967A JP2025116068A (ja) | 2021-05-25 | 2025-05-26 | 腎臓活性融合タンパク質及びそれを使用する治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192835P | 2021-05-25 | 2021-05-25 | |
| US63/192,835 | 2021-05-25 | ||
| PCT/US2022/030658 WO2022251168A1 (en) | 2021-05-25 | 2022-05-24 | Kidney active fusion proteins and methods of treatment using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025086967A Division JP2025116068A (ja) | 2021-05-25 | 2025-05-26 | 腎臓活性融合タンパク質及びそれを使用する治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520421A JP2024520421A (ja) | 2024-05-24 |
| JP2024520421A5 true JP2024520421A5 (https=) | 2025-06-04 |
Family
ID=84178944
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572788A Pending JP2024520421A (ja) | 2021-05-25 | 2022-05-24 | 腎臓活性融合タンパク質及びそれを使用する治療方法 |
| JP2025086967A Pending JP2025116068A (ja) | 2021-05-25 | 2025-05-26 | 腎臓活性融合タンパク質及びそれを使用する治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025086967A Pending JP2025116068A (ja) | 2021-05-25 | 2025-05-26 | 腎臓活性融合タンパク質及びそれを使用する治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240262877A1 (https=) |
| EP (1) | EP4347666A4 (https=) |
| JP (2) | JP2024520421A (https=) |
| KR (1) | KR20240013770A (https=) |
| CN (1) | CN117396519A (https=) |
| AU (1) | AU2022283254A1 (https=) |
| BR (1) | BR112023024627A2 (https=) |
| CA (1) | CA3177162A1 (https=) |
| IL (1) | IL308754A (https=) |
| MX (1) | MX2023014037A (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL301713A (en) * | 2020-10-05 | 2023-05-01 | Alexion Pharma Inc | Methods for treating dermatomyositis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1218409A2 (en) * | 2000-03-13 | 2002-07-03 | St. Vincent's Hospital (Melbourne) Limited | Factor-h related protein 5 (fhr-5) and antibodies thereto |
| US7759304B2 (en) * | 2006-06-21 | 2010-07-20 | Regents Of The University Of Colorado | Targeting complement factor H for treatment of diseases |
| US9815876B2 (en) * | 2010-03-05 | 2017-11-14 | Omeros Corporation | Chimeric inhibitor molecules of complement activation |
| CA2920293A1 (en) * | 2013-08-16 | 2015-02-19 | Alexion Pharmaceuticals, Inc. | Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant |
| WO2018075462A1 (en) * | 2016-10-17 | 2018-04-26 | Medical University Of South Carolina | Compositions and methods for treating and preventing transplant-associated injury |
-
2022
- 2022-05-24 AU AU2022283254A patent/AU2022283254A1/en active Pending
- 2022-05-24 BR BR112023024627A patent/BR112023024627A2/pt unknown
- 2022-05-24 US US18/561,469 patent/US20240262877A1/en active Pending
- 2022-05-24 CN CN202280035932.2A patent/CN117396519A/zh active Pending
- 2022-05-24 MX MX2023014037A patent/MX2023014037A/es unknown
- 2022-05-24 EP EP22811954.1A patent/EP4347666A4/en active Pending
- 2022-05-24 CA CA3177162A patent/CA3177162A1/en active Pending
- 2022-05-24 KR KR1020237044189A patent/KR20240013770A/ko active Pending
- 2022-05-24 IL IL308754A patent/IL308754A/en unknown
- 2022-05-24 JP JP2023572788A patent/JP2024520421A/ja active Pending
-
2025
- 2025-05-26 JP JP2025086967A patent/JP2025116068A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI648401B (zh) | 生長分化因子１５（ｇｄｆ－１５）構築體 | |
| JP4958975B2 (ja) | インスリン様増殖因子ｉの製造方法 | |
| CN101511390B (zh) | 制备胰岛素样生长因子-1与聚(乙二醇)的偶联物的方法 | |
| JP2014519852A5 (https=) | ||
| RU2011138951A (ru) | Пропротеины и способы их применения | |
| JP2014522641A (ja) | リラキシン融合ポリペプチドおよびその使用 | |
| CN108992661B (zh) | 一种多肽在制备静脉、腹腔或鼻腔给药药物中的应用 | |
| JP2015504675A5 (https=) | ||
| JP2024016234A (ja) | 変異型ｒｓｖ ｆタンパク質及びその利用 | |
| JP2011518179A5 (https=) | ||
| JP2014520148A (ja) | 治療のための神経筋接合部への標的化 | |
| JP2022118184A (ja) | コンジュゲートされたｃ１エステラーゼインヒビター及びその使用 | |
| CN117186239A (zh) | 融合蛋白及其应用 | |
| JP2002511847A (ja) | Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓに関連した歯周病の診断および治療のための合成ペプチド構築物 | |
| CN108727486A (zh) | 长效神经生长因子、制备方法及其组合物 | |
| JP2024520421A5 (https=) | ||
| CN109265558B (zh) | 改进型齐考诺肽在制备药物中的应用 | |
| CN109265557B (zh) | 一种齐考诺肽和tat肽的融合多肽在制备药物中的应用 | |
| CN109232744B (zh) | 改进型齐考诺肽 | |
| CN118922203A (zh) | 嵌合多肽 | |
| EP2846819A1 (en) | Variants of tace pro-domain as tnf-a inhibitor and their medical use | |
| JP6675306B2 (ja) | かゆみの抑制 | |
| CA2223503A1 (en) | Transferrin receptor genes | |
| WO2023196913A2 (en) | Methods of treating ankylosing spondylitis | |
| US10421796B2 (en) | Variants of IgG Fc with limited amine groups |